Hormel
HRL
$20.84
-0.62%
Hormel Foods Corporation is a global branded food company that produces and markets a wide range of meat and food products, including perishable proteins like fresh pork, turkey, and deli meats, as well as shelf-stable items such as Spam, Skippy peanut butter, and Planters nuts, operating primarily in the packaged foods industry. As a market leader with iconic brands holding number one or two positions in their categories, Hormel differentiates itself through a diversified portfolio spanning retail, foodservice, and international channels, with a strong presence in the US market. The current investor narrative centers on the company's strategic pivot toward higher-margin value-added products, including the divestiture of its volatile whole-bird turkey business, while grappling with persistent demand weakness, recent revenue misses, and a guidance cut that have raised concerns about growth and dividend sustainability, despite a solid earnings beat in the prior quarter that hinted at a potential turnaround.…
HRL
Hormel
$20.84
Related headlines
Investment Opinion: Should I buy HRL Today?
Based on the analysis, Hormel Foods is rated a Hold. The stock is trading at $21.54, which is below the analyst average target of $26.13, implying a potential upside of 21.3%. However, the consensus recommendation is 'hold,' reflecting uncertainty about the company's turnaround prospects. The thesis is that Hormel's strategic pivot to higher-margin products and its strong brand portfolio could drive earnings recovery, but near-term headwinds from demand weakness and margin pressures limit upside.
Sign up to view all
HRL 12-Month Price Forecast
The AI assessment is neutral with medium confidence. Hormel's valuation is not demanding on a forward basis, but the company faces significant operational challenges. The key to the thesis is whether the strategic pivot can restore earnings growth and margin expansion. If the company delivers on its turnaround, the stock could re-rate higher, but if it fails, the dividend and stock price are at risk. I would upgrade to bullish if the company shows consistent revenue growth above 3% and margin improvement, and downgrade to bearish if the dividend is cut or guidance is reduced again.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Hormel's 12-month outlook, with a consensus price target around $26.13 and implied upside of +25.4% versus the current price.
Average Target
$26.13
0 analysts
Implied Upside
+25.4%
vs. current price
Analyst Count
—
covering this stock
Price Range
$23 - $30
Analyst target range
The target price range spans from a low of $23.00 to a high of $30.00, with the average at $26.13, indicating a wide spread of 30.4% between the low and high, which signals significant uncertainty about Hormel's future performance. The high target of $30.00 assumes a successful execution of the company's strategic pivot to higher-margin products, margin expansion, and a recovery in demand, potentially leading to multiple expansion. The low target of $23.00 prices in continued demand weakness, potential dividend cuts, and further margin compression, reflecting the bearish scenario. The recent ratings actions, including the JP Morgan downgrade and the absence of any upgrades, suggest that analysts are not yet convinced of a turnaround, and the wide target range highlights the high level of uncertainty surrounding the stock's outlook.
Bulls vs Bears: HRL Investment Factors
Hormel Foods presents a mixed picture: while its forward valuation and strategic divestitures suggest potential for earnings recovery, the company is grappling with stagnant revenue, margin pressures, and a dividend payout ratio that exceeds 100%. The bearish case currently holds stronger evidence, as the stock's technical downtrend, recent guidance cut, and analyst downgrades outweigh the potential benefits of the turkey divestiture and brand strength. The most critical tension is whether Hormel can successfully execute its pivot to higher-margin products and restore earnings growth, which would justify the low forward PE and support the dividend. If the company fails to deliver on this front, the stock could test its 52-week low, but if it succeeds, there is significant upside to the analyst average target of $26.13.
Bullish
- Forward PE implies earnings recovery: The forward PE of 13.87x is significantly lower than the trailing PE of 27.29x, indicating the market expects a sharp rebound in EPS. Analysts estimate forward EPS of $1.67, which would represent a substantial increase from the depressed trailing earnings, driven by cost savings and strategic initiatives.
- Strategic divestiture of turkey unit: Hormel sold its volatile whole-bird turkey business to focus on higher-margin value-added proteins. This move is designed to stabilize earnings and reduce exposure to commodity price swings, potentially improving profitability and multiple expansion.
- Strong brand portfolio and market positions: Hormel's major brands, including Spam, Skippy, and Planters, hold number one or two market share in their categories. This brand strength provides pricing power and resilience in a competitive packaged foods market, supporting long-term revenue stability.
- Solid balance sheet with low debt: The debt-to-equity ratio is only 0.36, and the current ratio is 2.47, indicating a strong liquidity position. This financial flexibility allows Hormel to invest in growth initiatives, maintain dividends, and weather operational challenges without excessive leverage.
Bearish
- Persistent revenue stagnation and misses: Q2 FY2026 revenue grew only 2.55% YoY, but this was a deceleration from the prior quarter and marked a miss against estimates. The company has also cut its full-year guidance, reflecting ongoing demand weakness and input cost pressures, particularly in turkey and pork operations.
- Stock in clear downtrend, near 52-week low: The stock is trading at $21.54, only 9.3% above its 52-week low of $19.70, and has declined 14.66% over the past year. The price is at 20.6% of its 52-week range, indicating persistent selling pressure and a bearish technical setup.
- High payout ratio threatens dividend: The payout ratio of 132% indicates that Hormel is paying out more in dividends than it earns, which is unsustainable in the long run. If earnings do not recover, the company may be forced to cut its dividend, which would be a major negative catalyst for income-focused investors.
- Analyst downgrades and lack of upgrades: Recent ratings actions include a JP Morgan downgrade, and there have been no upgrades. The analyst consensus is a 'hold' with a mean rating of 2.6, reflecting skepticism about the company's ability to execute a turnaround.
HRL Technical Analysis
Hormel's stock is in a clear downtrend, with the price at $21.54 as of September 4, 2026, reflecting a 14.66% decline over the past year. The stock is trading at 20.6% of its 52-week range (between the low of $19.70 and high of $26.60), positioning it near the lower end, which suggests a bearish sentiment and potential value trap rather than a buying opportunity. The 52-week low of $19.70 was tested in May 2026, and the stock has since failed to sustain rallies, indicating persistent selling pressure.
Beta
0.32
0.32x market volatility
Max Drawdown
-32.5%
Largest decline past year
52-Week Range
$20-$27
Price range past year
Annual Return
-16.5%
Cumulative gain past year
| Period | HRL Return | S&P 500 |
|---|---|---|
| 1m | -14.2% | -1.6% |
| 3m | -15.8% | +2.2% |
| 6m | -8.0% | +14.4% |
| 1y | -16.5% | +16.2% |
| ytd | -10.9% | +11.1% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
HRL Fundamental Analysis
Hormel's revenue growth has been sluggish, with the most recent quarter (Q2 FY2026, ending April 26, 2026) reporting revenue of $2.97 billion, a modest 2.55% year-over-year increase, but this was a deceleration from the prior quarter's 1.3% growth and marked a miss against analyst estimates. The company's revenue trajectory has been inconsistent, with Q1 FY2026 revenue of $3.03 billion and Q4 FY2025 revenue of $3.19 billion, reflecting a sequential decline, and the Q2 FY2026 revenue was actually lower than the year-ago quarter's $2.90 billion, indicating stagnation. Segment-wise, Retail (62.2% of sales) and Foodservice (33.6%) are the primary drivers, but International (4.1%) has been a drag, with recent losses in that segment contributing to the overall weakness. The company's growth is being challenged by soft consumer demand and input cost pressures, particularly in its turkey and pork operations, which has led to a cautious outlook and a guidance cut for the full year.
Quarterly Revenue
$3.0B
2026-04
Revenue YoY Growth
+2.5%
YoY Comparison
Gross Margin
17.4%
Latest Quarter
Free Cash Flow
$692940000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is HRL Overvalued?
Given Hormel's positive net income, I selected the price-to-earnings (PE) ratio as the primary valuation metric. The trailing PE stands at 27.29x, while the forward PE is 13.87x, implying that the market expects a significant earnings recovery, as the forward multiple is substantially lower, reflecting anticipated growth in EPS from the current depressed levels. The gap between trailing and forward PE suggests that analysts project a sharp rebound in profitability, likely driven by cost savings and strategic initiatives, but this also indicates that the current earnings power is weak, and the stock is not cheap on a trailing basis.
PE
27.3x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 19x~34x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
15.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are significant for Hormel. The company's revenue growth has been sluggish, with Q2 FY2026 revenue of $2.97 billion only 2.55% higher YoY, and it missed analyst estimates, leading to a guidance cut. The net margin is thin at 3.95%, and the operating margin is only 5.94%, indicating limited profitability and high sensitivity to input costs. The dividend payout ratio of 132% is a major red flag, as it suggests the company is paying out more than it earns, which could force a dividend cut if earnings do not recover. Additionally, the company's free cash flow of $693 million TTM provides some cushion, but it is not sufficient to cover the dividend indefinitely if earnings remain depressed. The company's reliance on the volatile pork and turkey markets adds operational risk, as evidenced by the recent losses in the international segment.
FAQ
The key risks are: 1) Financial risk: the dividend payout ratio of 132% could force a dividend cut if earnings do not recover. 2) Operational risk: revenue growth is stagnant at 2.55% YoY, and the company has missed estimates, leading to guidance cuts. 3) Competitive risk: Hormel faces intense competition in packaged foods, which could pressure market share and margins. 4) Macro risk: input cost inflation and consumer demand weakness could further hurt profitability. The most severe risk is a dividend cut, which would likely cause the stock to fall to its 52-week low of $19.70.
The 12-month forecast for HRL is uncertain, with a base case probability of 45% that the stock reaches the analyst average target of $26.13, a bull case probability of 25% that it reaches $30.00, and a bear case probability of 30% that it falls to $23.00 or lower. The most likely scenario is a gradual recovery as the company executes its strategic pivot, but the bear case is almost as likely due to ongoing demand weakness. The key assumption for the base case is that revenue growth stabilizes and margins improve, allowing the company to maintain its dividend.
On a trailing basis, HRL appears overvalued with a PE of 27.29x, but on a forward basis, it is undervalued with a PE of 13.87x, implying the market expects a significant earnings recovery. The PS ratio of 1.08x is below the industry average, and the EV/EBITDA of 15.17x is moderate. Compared to its own history, the stock is trading near the lower end of its valuation range, suggesting it is not expensive. The market is pricing in a turnaround, and if earnings do not improve, the stock could be considered overvalued.
HRL is a hold for most investors. The stock offers a high dividend yield of 4.85% and trades at a forward PE of 13.87x, which is attractive if earnings recover. However, the company has missed revenue estimates and cut guidance, and the dividend payout ratio is 132%, raising sustainability concerns. The analyst average target of $26.13 implies 21% upside, but the wide range of targets ($23-$30) reflects high uncertainty. For income investors with a long-term horizon, HRL could be a good buy if they believe the strategic pivot will succeed, but for growth-oriented investors, there are better opportunities elsewhere.
HRL is more suitable for long-term investment, given its defensive nature, strong brands, and high dividend yield. The stock has a beta of 0.315, indicating low volatility, and its dividend provides a cushion during market downturns. However, the near-term outlook is uncertain, with the stock in a downtrend and facing operational challenges. For short-term traders, the stock's negative momentum and lack of catalysts make it less attractive. A minimum holding period of 3-5 years is recommended to allow the strategic initiatives to play out and for the dividend to be sustained.